Lung infections. 1. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers.Environmental health perspectives · 2008
   Trial
2. Advances in nanotechnology for the therapy of bacterial pneumonia.Frontiers in cellular and infection microbiology · 2025
   Review
3. Protracted bacterial bronchitis: The last decade and the road ahead.Pediatric pulmonology · 2016
   Review
4. Gaining the Upper Hand on Pulmonary Drug Delivery.Journal of pharmacovigilance · 2014
   Article
5. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.BMC medicine · 2013
   Review
6. Impact of statins and ACE inhibitors on mortality after COPD exacerbations.Respiratory research · 2009
   Article
7. Inflammatory mechanisms in the lung.Journal of inflammation research · 2009
   Article
8. Role of antimicrobial agents in the management of exacerbations of COPD.Treatments in respiratory medicine · 2005
   Review
9. Factors influencing airway inflammation in chronic obstructive pulmonary disease.Thorax · 2000
   Review
10. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.Thorax · 2000
    Article
11. Mandibular advancement oral appliance therapy for obstructive sleep apnoea: effect on awake calibre of the velopharynx.Thorax · 1999
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as